Evobrutinib reduces relapses and MRI outcomes in MS: association with baseline serum neurofilament light chain levels

Kuhle, J; Kappos, L; Montalban, X; Li, Y; Thangavelu, K; Hyvert, Y; Tomic, D

EUROPEAN JOURNAL OF NEUROLOGY, 2022; 29 (): 290